Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Australian Cancer Study(University of Copenhagen), Guillermo Pita(Spanish National Cancer Research Centre), Yi Lu(Karolinska Institutet), Jonathan P. Tyrer(University of Cambridge), Phuong L. Mai, Maren Weischer(University of Copenhagen), Daniel C. Tessier(McGill University and Génome Québec Innovation Centre), Shahana Ahmed(University of Cambridge), Joe Dennis(University of Cambridge), Karen A. Pooley(University of Cambridge), Caroline Baynes(University of Cambridge), Anna González‐Neira(Spanish National Cancer Research Centre), Daniel Barrowdale(University of Cambridge), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Michael D. Stutz(Walter and Eliza Hall Institute of Medical Research), Melanie Maranian(University of Cambridge), Juliet D. French(The University of Queensland), Ignace Vergote(KU Leuven), Françis Bacot(University of Washington), Evelyn Despierre(KU Leuven), Hilda A. Pickett(Cancer Clinic), Rod Karevan(University of Southern California), Chanel E. Smart(Vita-Salute San Raffaele University), Maya Ghoussaini(Regeneron (United States)), Kate Lawrenson(Texas A&M University – San Antonio), Stig E. Bojesen(University of Copenhagen), Rebecca L. Johnston(QIMR Berghofer Medical Research Institute), Stacey L. Edwards(Queensland University of Technology), Nicholas T. Woods(University of Nebraska Medical Center), Australian Ovarian Cancer Study(QIMR Berghofer Medical Research Institute), Qin Wang(University of Cambridge), Andrew Lee(University of Cambridge), Xiaoqing Chen(QIMR Berghofer Medical Research Institute), Daniel Vincent(The Netherlands Cancer Institute), Sharon E. Johnatty(University of Southern California), Mary Anne Rossing(Fred Hutch Cancer Center), Lesley McGuffog(University of Cambridge), Sue Healey(QIMR Berghofer Medical Research Institute), Sandrina Lambrechts(Dartmouth College), Sune F. Nielsen(Herlev Hospital), Manjeet K. Bolla(University of Cambridge), Howard C. Shen(University of Southern California), Kristine M. Hillman(The University of Queensland), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Gene Environment Interaction and Breast Cancer (GENICA)(QIMR Berghofer Medical Research Institute), Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE)(University of Cambridge), Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO)(The University of Queensland), Harvey A. Risch(University of New Haven), Swedish Breast Cancer Study (SWE-BRCA)(University of Cambridge), Michael Lush(University of Cambridge)
Cited by 544
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k